Table 1.
Demographic characteristics of subjects
| Parameter | Warfarin/rivaroxaban (n = 28) | Warfarin/placebo (n = 28) | Rivaroxaban alone (n = 28) |
|---|---|---|---|
| Age (years) | |||
| Median (range) | 30.5 (19.0–44.0) | 30.0 (18.0–44.0) | 35.5 (18.0–45.0) |
| SD | 7.2 | 7.5 | 8.0 |
| Weight (kg) | |||
| Mean (range) | 80.7 (63.0–108.0) | 78.3 (53.0–97.0) | 80.9 (62.0–101.0) |
| SD | 9.4 | 10.9 | 10.8 |
| Height (cm) | |||
| Mean (range) | 180 (166.0–197.0) | 179.8 (162.0–193.0) | 180.5 (167.0–194.0) |
| SD | 7.5 | 7.1 | 7.0 |
| Body mass index (kg m−2) | |||
| Mean (range) | 24.9 (20.9–29.0) | 24.1 (19.5–29.0) | 24.8 (18.6–29.5) |
| SD | 2.2 | 2.8 | 2.9 |